COMMUNIQUÉS West-GlobeNewswire

Celsion Corporation Provides Corporate Update and 2018 Outlook
18/01/2018
Company Advances ThermoDox® for Treatment of Primary Liver Cancer Following Independent Data Monitoring Committee’s Unanimous Recommendation to Continue Phase III OPTIMA Study OPTIMA Study Enrollment Reached 74% [...]
Radient Technologies Inc. Announces Key Management Appointment to RTI Global Health and Wellness Solutions
18/01/2018
EDMONTON, Alberta, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. ("Radient" or the “Corporation”) (TSX-V: RTI ) is pleased to announce the appointment of Dr. Marilena Radoiu to a key management role in its [...]
Argos Announces One-for-Twenty Reverse Stock Split
18/01/2018
DURHAM, N.C., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]
Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes
18/01/2018
BASKING RIDGE, N.J. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency
18/01/2018
BROOKLYN, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
DiaMedica Letter to Shareholders
18/01/2018
MINNEAPOLIS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“ DiaMedica ”) (TSX VENTURE:DMA) (OTCQB:DMCAF), provides corporate update. As we enter into 2018, we wanted to thank you, our shareholders, for [...]
REPEAT: Cannabis Wheaton Income Corp. Announces Closing of $100 Million Private Placement of Convertible Debenture Units
18/01/2018
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce the closing of its [...]
Loop Industries Announces Strategic Initiative to Support evian’s Commitment to Adopt a Circular Approach to Plastic Usage
18/01/2018
MONTREAL, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ: LOOP ) (the “Company” or “Loop”), a leader in the sustainable plastic revolution, today announced a strategic initiative with evian® as part of [...]
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome
18/01/2018
DUBLIN, Ireland and TREVOSE, Pa., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
The Joint Corp. Opens 400th Clinic
18/01/2018
SCOTTSDALE, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, reached 400 open clinics systemwide in January, 2018, having [...]
Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development
18/01/2018
HALIFAX, Nova Scotia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has appointed Joseph Sullivan to the newly created [...]
Angel Yeast Co., Ltd. signs exclusive global licence agreement with Renaissance BioScience Corp. for wine, cider and craft beer yeast
18/01/2018
YICHANG, China and VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Angel Yeast Co., Ltd., a Shanghai Stock Exchange listed company (SSE:600298), has signed a global licence agreement with Renaissance [...]
Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis
18/01/2018
NEW HAVEN, Conn., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]
THC Therapeutics becomes Millennium Blockchain
18/01/2018
LAS VEGAS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (“THCT” or the “Company,”) (OTC:THCT) is pleased to announce that it is changing its direction to blockchain technology. The Company is changing its [...]
Purepoint Uranium Reports on First Seven Holes at Hook Lake, Extending Spitfire Strike Length by 25%
18/01/2018
TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (the “ Company ” or “ Purepoint ”) (TSX.V:PTU) today reported the completion of the first seven holes of the 2017/2018 Winter drill program at the [...]
Diffusion Pharmaceuticals Announces $12 Million Underwritten Public Offering
18/01/2018
CHARLOTTESVILLE, Va., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN ) (“Diffusion” or the “Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars
18/01/2018
Collaboration aims to help patients worldwide gain access to a range of high-quality, affordable immunology and oncology biologics Partnership will be an important part of Sandoz and Biocon strategy to address the next [...]
Ossur Hf : Q4/FY 2017 Results - Conference call Tuesday 6 February at 9:00 CET
18/01/2018
Announcement from Össur hf. no: 4/2018 Conference call on Tuesday 6 February at 9:00 CET / 8:00 GMT / 3:00 EDT After market closing on Monday 5 February, Össur will publish its financial results for Q4 and the full year [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
18/01/2018
FIT Biotech Oy Company release January 18, 2018 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Pages